MPLNET.com » News » MPLN contributes to FDA approval of the Panther System Client Login | Email | Phone: 1.800.932.2943

MPLN contributes to FDA approval of the Panther System


Posted on September 27, 2012 by Jonathan Mulkey

MPLN, through it's Geneuity Clinical Research Services Division, participated in the instrument performance evaluations that contributed to the FDA approval of the Panther(TM) system for use with the APTIMA 2 Combo assay, particularly testing for the common sexually transmitted infections Chlamydia trachomatis and Neisseria gonorrhoeae.  "It is a credit to the scores of talented and dedicated scientists and engineers who made it happen.  We believe that PANTHER will continue that revolution by bringing the power of fully-automated, sample to result capabilities to low- and medium- volume labs.," said Carl Hull, Gene-Probe's chairman and chief executive officer.

Commenting is turned off for this post.

Commenting is not available in this channel entry.